Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1998Antimicrobial Agents and ChemotherapyOpen Access

Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWeixing LiNanjing Tech UniversityPEPaul A. EscarpeAustralian National UniversityEEEugene EisenbergSan Francisco General Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (1998) studied this question.

synapsesocial.com/papers/6a772835a0847c3df1ec5aebhttps://doi.org/10.1128/aac.42.3.647
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection1998 · 257 citations
  2. 2Respiratory Infections—Diagnosis and Management1995 · 187 citations
  3. 3Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.1987 · 322 citations
  4. 4Advances in Influenza Virus Vaccine Researcha1993 · 61 citations